Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Integrated Research stock price, quote, forecast and news

IRI.AX
AU000000IRI3

Price

0.60 AUD
Today +/-
-0.01 AUD
Today %
-2.47 %
P

Integrated Research stock price

AUD
%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Integrated Research stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Integrated Research stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Integrated Research stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Integrated Research's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Integrated Research Stock Price History

DateIntegrated Research Price
8/23/20240.60 AUD
8/22/20240.62 AUD
8/21/20240.59 AUD
8/20/20240.66 AUD
8/19/20240.76 AUD
8/16/20240.79 AUD
8/15/20240.77 AUD
8/14/20240.76 AUD
8/13/20240.77 AUD
8/12/20240.76 AUD
8/9/20240.75 AUD
8/8/20240.74 AUD
8/7/20240.76 AUD
8/6/20240.83 AUD
8/5/20240.84 AUD
8/2/20240.93 AUD
8/1/20240.94 AUD
7/31/20240.89 AUD
7/30/20240.87 AUD
7/29/20240.85 AUD

Integrated Research Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Integrated Research, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Integrated Research from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Integrated Research’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Integrated Research. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Integrated Research’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Integrated Research’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Integrated Research’s growth potential.

Integrated Research Revenue, EBIT and net profit per share

DateIntegrated Research RevenueIntegrated Research EBITIntegrated Research Net Income
2027e84.94 M AUD35.52 M AUD15.17 M AUD
2026e82.92 M AUD19.08 M AUD14.99 M AUD
2025e82.21 M AUD19.45 M AUD16.22 M AUD
2024e83.22 M AUD23.32 M AUD21.87 M AUD
202369.83 M AUD-544,000 AUD-29.23 M AUD
202262.87 M AUD-7.28 M AUD1.55 M AUD
202178.49 M AUD9.78 M AUD7.94 M AUD
2020110.91 M AUD32.73 M AUD24.05 M AUD
2019100.82 M AUD27.59 M AUD21.85 M AUD
201891.18 M AUD25.78 M AUD19.18 M AUD
201791.17 M AUD27.14 M AUD18.52 M AUD
201684.53 M AUD21.42 M AUD16.03 M AUD
201570.28 M AUD17.47 M AUD14.25 M AUD
201453.2 M AUD10.7 M AUD8.5 M AUD
201348.9 M AUD10.5 M AUD9.1 M AUD
201248.6 M AUD11.2 M AUD9 M AUD
201144.6 M AUD10.5 M AUD7.5 M AUD
201037.3 M AUD5.7 M AUD5.4 M AUD
200942.7 M AUD9.4 M AUD7.9 M AUD
200837.4 M AUD7.2 M AUD5.8 M AUD
200736.4 M AUD7 M AUD5.4 M AUD
200634.5 M AUD7.6 M AUD7 M AUD
200533.3 M AUD8.3 M AUD6.2 M AUD
200430.3 M AUD7.2 M AUD4.5 M AUD

Integrated Research Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M AUD)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M AUD)EBIT (M AUD)EBIT MARGIN (%)NET INCOME (M AUD)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e2027e
28322830333436374237444848537084919110011078626983828284
-14.29-12.507.1410.003.035.882.7813.51-11.9018.929.09-10.4232.0820.008.33-9.8910.00-29.09-20.5111.2920.29-1.20-2.44
--------------------100.00100.00100.00----
000000000000000000007862690000
7817877795101110101721272527329-7023191935
25.0025.003.5723.3324.2420.5919.4418.9221.4313.5122.7322.9220.8318.8724.2925.0029.6727.4727.0029.0911.54-11.29-27.7123.1723.1741.67
5614675575799814161819212471-2921161415
-20.00-83.33300.0050.0016.67-28.57-40.00-28.5740.0028.57--11.1175.0014.2912.505.5610.5314.29-70.83-85.71-3,000.00-172.41-23.81-12.507.14
165.3165.4165.3165.8166.2165.8167.4166.6166.9167.5167.1168.1169.7169.9170.92171.65171.76172.07172.11172.53172.6172.89172.90000
---------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Integrated Research Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Integrated Research is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M AUD)RECEIVABLES (M AUD)OTHER REC. (M AUD)INVENTORIES (M AUD)OTHER CURRENT LIAB. (M AUD)CURRENT ASSETS (M AUD)TANGIBLE ASSETS (M AUD)LONG-T. INVEST. (M AUD)LONG-T. REC. (M AUD)INTANGIBLE ASSETS (M AUD)GOODWILL (M AUD)OTHER NON-CURRENT ASSETS (M AUD)NON-CURRENT ASSETS (M AUD)TOTAL ASSETS (M AUD)LIABILITIESCOMMON STOCK (M AUD)ADDITIONAL PAID-IN CAPITAL (M AUD)RETAINED EARNINGS (M AUD)OTHER EQUITY (M AUD)UNREAL. GAINS/LOSSES (M AUD)EQUITY (M AUD)LIABILITIES (M AUD)PROVISIONS (M AUD)OTHER SHORT-TERM LIAB. (M AUD)SHORT-TERM DEBTS (M AUD)LONG-TERM DEBT PORTION (M AUD)SHORT-TERM REC. (M AUD)LONG-T. LIAB. (M AUD)DEFERRED TAXES (M AUD)OTHER LIAB. (M AUD)LONG-T. LIABILITIES (M AUD)DEBT (M AUD)TOTAL CAPITAL (M AUD)
2002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
4.56.29.911.112.111.711.114.58.411.61214.813.315.328.5414.1111.249.329.7412.1512.3318.55
12.27.610.410.113.611.210.110.914.51420.621.320.124.9228.935.7844.0352.1558.6252.5547.6541.93
2.42.30.90.30.30.81.11.80.40.80.30.10.70.280.281.371.20.480.240.870.90.34
0000000000000000000000
2.62.91.822.31.30.92.20.91.210.811.341.781.861.792.12.022.552.492.23
21.7192323.528.32523.229.424.227.633.93735.141.8639.5153.1358.2564.0570.6268.1163.3663.05
0.8111.21.32.92.42.42.11.91.81.71.71.971.791.872.552.638.257.265.150
000001.71.81.81.81.81.80.70.80.80.820.170.260.240.240.180.241.4
0.70.40.2000001.510.72.22.613.2623.3723.326.8922.2230.2728.3923.0523.75
7.57.78.310.29.611.412.613.31413.813.81516.317.0218.6816.7318.619.5825.4226.6727.730
000000000000003.293.23.333.523.633.293.580
0.61.91.60.60.40.20.30.40.70.30.51.21.51.341.491.150.691.291.41.181.331.51
9.61111.11211.316.217.117.920.118.818.620.822.934.3949.4546.4252.3249.4769.2166.9761.0826.66
31.33034.135.539.641.240.347.344.346.452.557.85876.2688.9699.55110.57113.52139.84135.08124.4489.71
0.40.40.40.50.50.70.80.80.80.81.21.51.71.671.671.671.671.671.671.671.671.67
0000000000000000000000
15.21518.221.122.823.52427.125.128.329.830.730.335.139.8147.5856.5767.7280.0382.3484.8156.34
000000-1-0.7-1.4-1.8-1.8-2.1-1.2-0.64-0.44-0.72-0.40.440.83-0.670.641.87
0000000000000000000000
15.615.418.621.623.324.223.827.224.527.329.230.130.836.1341.0548.5257.8469.8382.5283.3487.1159.87
1.23.52.61.82.42.22.42.93.13.44.34.24.17.248.519.6210.149.810.2110.1810.137.9
0000000000002.12.332.622.613.093.23.854.053.653.07
12.18.610.29.211.511.310.111.912.311.913.316.413.821.0223.7924.3924.9623.192315.8414.7814.66
0000000000000000000000
0000000000000000001.371.661.711.58
13.312.112.81113.913.512.514.815.415.317.620.62030.5934.9236.6238.1836.1838.4331.7330.2727.21
00000000000000000010.1411.433.161.47
2.22.22.32.82.32.73.13.83.52.633.63.74.413.923.444.285.846.457.042.490
0.20.30.30.20.210.81.40.91.12.73.63.65.139.0810.9710.271.682.291.541.421.16
2.42.52.632.53.73.95.24.43.75.77.27.39.5412.9914.4114.557.5118.8820.017.062.63
15.714.615.41416.417.216.42019.81923.327.827.340.1347.9151.0352.7343.6957.3251.7337.3329.84
31.3303435.639.741.440.247.244.346.352.557.958.176.2688.9699.55110.57113.52139.84135.08124.4489.71
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Integrated Research provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Integrated Research's financial health and stability.

Assets

Integrated Research's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Integrated Research must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Integrated Research after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Integrated Research's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M AUD)DEPRECIATION (M AUD)DEFERRED TAXES (M AUD)CHANGES IN WORKING CAPITAL (M AUD)NON-CASH ITEM (M AUD)PAID INTEREST (M AUD)PAID TAXES (M AUD)NET CASH FLOW FROM OPERATING ACTIVITIES (M AUD)CAPITAL EXPENDITURES (M AUD)CASH FLOW FROM INVESTING ACTIVITIES (M AUD)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M AUD)INTEREST INCOME AND EXPENSES (M AUD)NET DEBT CHANGE (M AUD)NET CHANGE IN EQUITY (M AUD)CASH FLOW FROM FINANCING ACTIVITIES (M AUD)CASH FLOW FROM OTHER FINANCING ACTIVITIES (AUD)TOTAL DIVIDENDS PAID (M AUD)NET CHANGE IN CASH FLOW (M AUD)FREE CASH FLOW (M AUD)SHARE-BASED COMPENSATION (M AUD)
2002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
000000000000000000071-29
0000000000000000000221
00000000000000000000-4-2
0200000000000000000000
00000000000000000000-131
0000000000000000000000
0-3-1-100-1-10-1-1-2-2-1-3-7-7-6-6-30-1
14455757813141716211626212124211613
00000-200-6-6-7-8-8-10-10-9-12-12-15-12-11-7
00000-100-6-5-6-6-8-9-11-9-12-11-14-10-9-6
00000000000100-10000121
0000000000000000000000
00000000000000000030-6-1
0000000000000000000000
-2-2-1-3-4-4-5-4-7-4-7-8-9-10-11-11-11-12-9-7-7-1
----------------------
-2-2-1-3-4-4-5-5-7-4-7-8-9-10-11-11-11-12-12-600
068769612118162216251339262630261721
0.823.913.814.934.565.185.597.111.457.557.188.967.2711.256.1916.698.738.668.958.835.146.03
0000000000000000000000

Integrated Research stock margins

The Integrated Research margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Integrated Research. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Integrated Research.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Integrated Research's sales revenue. A higher gross margin percentage indicates that the Integrated Research retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Integrated Research's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Integrated Research's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Integrated Research's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Integrated Research. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Integrated Research's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Integrated Research Margin History

Integrated Research Gross marginIntegrated Research Profit marginIntegrated Research EBIT marginIntegrated Research Profit margin
2027e100 %41.82 %17.86 %
2026e100 %23 %18.08 %
2025e100 %23.66 %19.73 %
2024e100 %28.01 %26.28 %
2023100 %-0.78 %-41.85 %
2022100 %-11.58 %2.46 %
2021100 %12.46 %10.11 %
2020100 %29.51 %21.69 %
2019100 %27.36 %21.67 %
2018100 %28.28 %21.04 %
2017100 %29.77 %20.31 %
2016100 %25.34 %18.96 %
2015100 %24.85 %20.28 %
2014100 %20.11 %15.98 %
2013100 %21.47 %18.61 %
2012100 %23.05 %18.52 %
2011100 %23.54 %16.82 %
2010100 %15.28 %14.48 %
2009100 %22.01 %18.5 %
2008100 %19.25 %15.51 %
2007100 %19.23 %14.84 %
2006100 %22.03 %20.29 %
2005100 %24.92 %18.62 %
2004100 %23.76 %14.85 %

Integrated Research Stock Sales Revenue, EBIT, Earnings per Share

The Integrated Research earnings per share therefore indicates how much revenue Integrated Research has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Integrated Research earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Integrated Research's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Integrated Research’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Integrated Research's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Integrated Research Revenue, EBIT and net profit per share

DateIntegrated Research Sales per ShareIntegrated Research EBIT per shareIntegrated Research Earnings per Share
2027e0.49 AUD0 AUD0.09 AUD
2026e0.47 AUD0 AUD0.09 AUD
2025e0.47 AUD0 AUD0.09 AUD
2024e0.48 AUD0 AUD0.13 AUD
20230.4 AUD-0 AUD-0.17 AUD
20220.36 AUD-0.04 AUD0.01 AUD
20210.45 AUD0.06 AUD0.05 AUD
20200.64 AUD0.19 AUD0.14 AUD
20190.59 AUD0.16 AUD0.13 AUD
20180.53 AUD0.15 AUD0.11 AUD
20170.53 AUD0.16 AUD0.11 AUD
20160.49 AUD0.12 AUD0.09 AUD
20150.41 AUD0.1 AUD0.08 AUD
20140.31 AUD0.06 AUD0.05 AUD
20130.29 AUD0.06 AUD0.05 AUD
20120.29 AUD0.07 AUD0.05 AUD
20110.27 AUD0.06 AUD0.04 AUD
20100.22 AUD0.03 AUD0.03 AUD
20090.26 AUD0.06 AUD0.05 AUD
20080.22 AUD0.04 AUD0.03 AUD
20070.22 AUD0.04 AUD0.03 AUD
20060.21 AUD0.05 AUD0.04 AUD
20050.2 AUD0.05 AUD0.04 AUD
20040.18 AUD0.04 AUD0.03 AUD

Integrated Research business model

Integrated Research Ltd is a company based in Sydney, Australia, which was founded in 1988 by Steve Killelea and has been listed on the Australian Stock Exchange since 1993. The company operates globally and focuses on developing software that supports businesses in monitoring and analyzing IT infrastructures and business processes. The business model of Integrated Research is based on the fact that as businesses become more digitalized, they operate increasingly complex IT systems and business processes. Therefore, it is important to have comprehensive insight into the availability and performance of these systems. The company offers software solutions that help businesses detect and resolve problems early on to ensure the smooth operation of their IT infrastructure. Integrated Research covers various application areas, such as Unified Communications (UC), contact center management, and network monitoring. One of Integrated Research's most well-known software solutions is Prognosis, a powerful monitoring platform that provides real-time visibility into companies' IT infrastructures. Prognosis offers a wide range of modules that allow businesses to monitor and diagnose the health and performance of their core systems, such as UC and contact centers, in order to quickly resolve issues and minimize downtime. Another important product of Integrated Research is the call recording system, which provides a simple yet powerful way to record important activities of contact center employees. This is an extremely important feature for businesses operating in the financial services sector as it allows them to meet their compliance requirements. Integrated Research also offers a UC analytics solution that helps businesses gain detailed insights into interactions between employees, customers, and business partners. The UC analytics solution provides a comprehensive and flexible platform for conducting analyses, generating reports, and gaining insights that can help businesses improve their performance and reduce costs. The company places great emphasis on customer service and support. With its global presence in over 60 countries, Integrated Research is able to provide support and solutions to its customers around the clock. The company has received numerous awards for its customer satisfaction in the past. Integrated Research is a company that is constantly evolving to provide its customers with the best possible solutions. However, it has always remained true to its roots and philosophy, which is based on trust, integrity, and passion for technology and customer service. Integrated Research is one of the most popular companies on Eulerpool.com.

Integrated Research SWOT Analysis

Strengths

  • Integrated Research Ltd is a leading provider of performance management software solutions
  • The company has a strong and diverse customer base including major corporations across various industries
  • Integrated Research has a proven track record of delivering high-quality products and services
  • The company has a global presence with offices and customers in multiple regions
  • Integrated Research has a strong financial position and a history of consistent revenue growth

Weaknesses

  • The company is highly dependent on key customers, and a loss of any major contract could impact revenue
  • Integrated Research faces intense competition in the performance management software market
  • The company's success depends on its ability to continuously innovate and keep up with rapidly evolving technology
  • Integrated Research may face challenges in expanding into new markets and attracting new customers

Opportunities

  • There is a growing demand for performance management software as organizations strive to optimize their operations and improve efficiency
  • Integrated Research can capitalize on the increasing adoption of cloud-based solutions
  • The company can explore partnership opportunities with other software providers to enhance its product offerings
  • Integrated Research can expand its presence in emerging markets where there is a potential for significant growth

Threats

  • The performance management software market is highly competitive, and new entrants can pose a threat to Integrated Research's market share
  • Technological advancements and changing customer preferences may require the company to adapt and invest in research and development
  • Economic downturns could lead to reduced spending on software solutions, impacting Integrated Research's revenue
  • Political and regulatory changes in different regions may affect the company's ability to operate and expand internationally

Integrated Research Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Integrated Research historical P/E ratio, EBIT, and P/S ratio.

Integrated Research shares outstanding

The number of shares was Integrated Research in 2023 — This indicates how many shares 172.902 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Integrated Research earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Integrated Research's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Integrated Research’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Integrated Research's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Integrated Research dividend history and estimates

In 2023, Integrated Research paid a dividend amounting to 0 AUD. Dividend means that Integrated Research distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Integrated Research provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Integrated Research’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Integrated Research's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Integrated Research Dividend History

DateIntegrated Research Dividend
20200.1 AUD
20190.1 AUD
20180.09 AUD
20170.09 AUD
20160.08 AUD
20150.09 AUD
20140.06 AUD
20130.06 AUD
20120.06 AUD
20110.05 AUD
20100.03 AUD
20090.04 AUD
20080.03 AUD
20070.03 AUD
20060.03 AUD
20050.03 AUD
20040.11 AUD

Integrated Research dividend payout ratio

In 2023, Integrated Research had a payout ratio of 77.51%. The payout ratio indicates the percentage of the company's profits that Integrated Research distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Integrated Research represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Integrated Research could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Integrated Research's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Integrated Research Payout Ratio History

DateIntegrated Research Payout ratio
2027e78.3 %
2026e78.1 %
2025e78.21 %
2024e78.59 %
202377.51 %
202278.53 %
202179.72 %
202074.29 %
201981.58 %
201883.3 %
201782.54 %
201686.82 %
2015103.44 %
2014113.93 %
2013115.43 %
2012124.86 %
2011128.13 %
201091.48 %
200981.07 %
2008100 %
2007100 %
200662.5 %
200562.5 %
2004358.33 %
Unfortunately, there are currently no price targets and forecasts available for Integrated Research.

Integrated Research latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
12/31/20080.02 AUD0.02 AUD (0.58 %)2009 Q2
1

Eulerpool ESG Scorecard© for the Integrated Research stock

Eulerpool World ESG Rating (EESG©)

65/ 100

🌱 Environment

70

👫 Social

76

🏛️ Governance

48

Environment

Scope 1 - Direct Emissions
—
Scope 2 - Indirect emissions from purchased energy
—
Scope 3 - Indirect emissions within the value chain
—
Total CO₂ emissions
—
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
❌
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
❌
Environmentally friendly packaging
❌
Hazardous substances
❌
Fuel consumption and efficiency
❌
Water consumption and efficiency
❌

Social

Percentage of female employees—
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept✅
Privacy concept—
Occupational health and safety✅
Catholic✅

Governance (Corporate Governance)

Environmental reporting❌
Stakeholder Engagement❌
Call Back Policies❌
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Integrated Research list of shareholders

%
Name
Stocks
Change
Date
4.36 % Debenham (Nicholas Barry)7,606,720-994,2809/20/2023
29.71 % Killelea (Stephen John)51,880,61909/20/2023
1.72 % B & R James Investments Pty. Ltd.3,000,0003,000,0009/20/2023
1.60 % Rutherford (Andrew Rhys)2,794,21009/20/2023
1.55 % Santos L Helper Pty Ltd2,700,0001,659,0199/20/2023
0.91 % Navigator Australia Ltd.1,581,097-173,7709/20/2023
0.85 % DFA Australia Ltd.1,491,523-51112/31/2023
0.57 % Ghumman (Nirmal Kaur)1,001,0001,001,0009/20/2023
0.53 % Anacacia Pty. Ltd.922,441922,4419/20/2023
0.47 % Garrett Smythe, Ltd.828,928828,9289/20/2023
1
2
3

Integrated Research Executives and Management Board

Mr. John Ruthven
Integrated Research Chief Executive Officer, Managing Director, Executive Director (since 2019)
Compensation 1.22 M AUD
Mr. Mark Brayan
Integrated Research Non-Executive Director (since 2007)
Compensation 533,454 AUD
Mr. Matthew Walton
Integrated Research Interim Chief Financial Officer
Compensation 440,222 AUD
Mr. Peter Lloyd
Integrated Research Independent Non-Executive Chairman of the Board
Compensation 180,000 AUD
Ms. Catherine Aston
Integrated Research Independent Non-Executive Director
Compensation 100,000 AUD
1
2

Integrated Research Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
ServiceNow Stock
ServiceNow
SupplierCustomer0,540,680,520,710,51-0,48
Avaya Hldgs Stock
Avaya Hldgs
SupplierCustomer0,530,870,720,900,860,09
Cisco Systems Stock
Cisco Systems
SupplierCustomer0,500,690,590,780,28-0,75
BT Group Stock
BT Group
SupplierCustomer0,490,81--0,70-0,19-0,85
Hewlett Packard Enterp Stock
Hewlett Packard Enterp
SupplierCustomer0,350,380,32-0,04-0,69-0,87
NICE Stock
NICE
SupplierCustomer0,350,420,520,930,63-0,26
Ribbon Communications Stock
Ribbon Communications
SupplierCustomer0,290,720,390,950,930,08
Oracle Stock
Oracle
SupplierCustomer0,140,850,670,890,40-0,80
Zoom Video Communications A Stock
Zoom Video Communications A
SupplierCustomer-0,050,590,560,950,960,70
JPMorgan Chase Stock
JPMorgan Chase
SupplierCustomer-0,190,180,450,850,67-0,67
1
2

Most common questions regarding Integrated Research

What values and corporate philosophy does Integrated Research represent?

Integrated Research Ltd represents a strong commitment to innovation, excellence, and customer satisfaction. The company's corporate philosophy centers around delivering world-class software solutions and services that empower businesses to optimize their performance and ensure superior customer experiences. Integrated Research Ltd focuses on leveraging cutting-edge technologies and industry expertise to deliver actionable insights and intelligent automation. With a customer-centric approach, the company aims to build long-term partnerships and provide comprehensive support to meet the unique needs of its clients. In essence, Integrated Research Ltd stands for a dedication to success, leadership in technology, and delivering value to its stakeholders.

In which countries and regions is Integrated Research primarily present?

Integrated Research Ltd is primarily present in various countries and regions around the world. The company's presence can be found in Australia, North America, Europe, Asia-Pacific, and Latin America. With a global footprint, Integrated Research Ltd has established a strong presence in these regions, delivering its innovative solutions and services to customers worldwide.

What significant milestones has the company Integrated Research achieved?

Some significant milestones achieved by Integrated Research Ltd include becoming a publicly listed company on the Australian Stock Exchange in 2000, expanding its global presence with offices in North America, Europe, and Asia, and consistently delivering strong financial performance with steady revenue growth. The company has also forged strategic partnerships with major technology providers, enabling it to develop innovative and industry-leading solutions. Integrated Research Ltd has received multiple prestigious industry awards, acknowledging its commitment to delivering excellence in performance management and monitoring solutions for business-critical environments. These achievements demonstrate the company's continuous growth, market recognition, and dedication to providing cutting-edge solutions for its clients.

What is the history and background of the company Integrated Research?

Integrated Research Ltd is an Australian company that specializes in developing and providing performance management software solutions. Founded in 1988, Integrated Research has grown to become a leading global provider of monitoring, diagnostics, and business process automation solutions. The company's flagship product, Prognosis, offers real-time insights into critical IT infrastructure and business processes, allowing organizations to optimize performance, enhance customer experiences, and improve operational efficiency. With a strong focus on innovation and strategic partnerships, Integrated Research continues to expand its global presence and deliver cutting-edge solutions to help businesses across various industries achieve their performance goals.

Who are the main competitors of Integrated Research in the market?

Integrated Research Ltd faces competition from multiple companies in the market. Some of its main competitors include NICE Ltd, Verint Systems Inc, and CA Technologies. These companies also offer software solutions and services for business performance, customer experience management, and collaboration. Integrated Research differentiates itself through its innovative and comprehensive approach to monitoring and managing critical IT infrastructure and applications. With its strong market presence and reputation in the industry, Integrated Research continues to face competition but remains a leading player in the market.

In which industries is Integrated Research primarily active?

Integrated Research Ltd (IR) is primarily active in the software and technology industry. As a global provider of proactive performance management software, IR serves various sectors including banking and financial services, telecommunications, government, and healthcare. With its innovative solutions, IR helps organizations enhance their operational efficiency, resolve critical system issues, and maintain optimal performance across their networks.

What is the business model of Integrated Research?

Integrated Research Ltd (IRL) is an Australian-based software company specializing in performance management and critical business communication solutions. IRL's business model revolves around developing and delivering innovative software solutions that help organizations optimize and manage their critical IT infrastructure, communications, and payments. By offering a comprehensive suite of products, including Prognosis, IR Collaborate, and Payments Notification, IRL enables businesses to proactively monitor, measure, and enhance the performance of their mission-critical systems and applications. IRL's business model focuses on providing reliable and effective solutions that drive operational efficiency, increase customer satisfaction, and ensure smooth, uninterrupted business operations.

What is the P/E ratio of Integrated Research 2024?

The Integrated Research P/E ratio is 4.74.

What is the P/S ratio of Integrated Research 2024?

The Integrated Research P/S ratio is 1.25.

What is the AlleAktien quality score of Integrated Research?

The AlleAktien quality score for Integrated Research is 2/10.

What is the revenue of Integrated Research 2024?

The expected Integrated Research revenue is 83.22 M AUD.

How high is the profit of Integrated Research 2024?

The expected Integrated Research profit is 21.87 M AUD.

What is the business model of Integrated Research

Integrated Research Ltd is an IT company specializing in monitoring and managing business applications to ensure smooth business operations. Founded in 1988 and headquartered in Sydney, Australia, Integrated Research Ltd offers a wide range of solutions for IT infrastructure, communication, and collaboration for businesses. Its business model is based on three main divisions: forecasting and performance analytics, unified communications monitoring, and network management. Each division offers different products and services to help companies effectively manage their IT infrastructure. Overall, Integrated Research Ltd aims to support companies in effectively managing their IT infrastructure and ensuring seamless business operations.

What is the Integrated Research dividend?

Integrated Research pays a dividend of 0 AUD distributed over payouts per year.

How often does Integrated Research pay dividends?

The dividend cannot currently be calculated for Integrated Research or the company does not pay out a dividend.

What is the Integrated Research ISIN?

The ISIN of Integrated Research is AU000000IRI3.

What is the Integrated Research ticker?

The ticker of Integrated Research is IRI.AX.

How much dividend does Integrated Research pay?

Over the past 12 months, Integrated Research paid a dividend of 0.1 AUD . This corresponds to a dividend yield of about 17.26 %. For the coming 12 months, Integrated Research is expected to pay a dividend of 0 AUD.

What is the dividend yield of Integrated Research?

The current dividend yield of Integrated Research is 17.26 %.

When does Integrated Research pay dividends?

Integrated Research pays a quarterly dividend. This is distributed in the months of March, October, March, October.

How secure is the dividend of Integrated Research?

Integrated Research paid dividends every year for the past 4 years.

What is the dividend of Integrated Research?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Integrated Research located?

Integrated Research is assigned to the 'Information technology' sector.

Wann musste ich die Aktien von Integrated Research kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Integrated Research from 10/15/2020 amounting to 0.054 AUD, you needed to have the stock in your portfolio before the ex-date on 9/2/2020.

When did Integrated Research pay the last dividend?

The last dividend was paid out on 10/15/2020.

What was the dividend of Integrated Research in the year 2023?

In the year 2023, Integrated Research distributed 0 AUD as dividends.

In which currency does Integrated Research pay out the dividend?

The dividends of Integrated Research are distributed in AUD.

All fundamentals about Integrated Research

Our stock analysis for Integrated Research Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Integrated Research Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.